Expression and prognostic significance of NKD2 in ovarian cancer
- 15 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 51 (3) , 459-468
Abstract
Purpose: Naked2 (NKD2) is a negative regulator of Wnt signaling pathway and associates with transforming growth factor secretion. The role of NKD2 in ovarian cancer is unknown.Patients and methods: Gene expression profiles were measured and compared in nine patients by RNA sequencing. NKD2 expressions in ovarian cancer were measured by reverse transcription polymerase chain reaction and western blot. Tissue slides of 79 patients were stained and scored for NKD2 expression. In vitro experiments were conducted to explore the role of NKD2 in ovarian cancer. The prognostic role of NKD2 was evaluated by survival analysis.Results: NKD2 was upregulated in patients with better survival by mRNA and protein expression. Patients were classified as NKD2-high group (n = 30) and NKD2-low group (n = 49) according to immunohistochemical score. High NKD2 was correlated with lower recurrence rate (P = 0.002) and higher percentage of platinum-sensitive recurrence (P = 0.006). Median progression-free survival was significantly longer for NKD2-high patients than NKD2-low patients (49.1 vs.14.1 months, P < 0.001). Accordingly, there was a significantly difference in terms of overall survival time between two groups (hazard ratio: 3.04; 95% confidence interval: 1.58–5.85, P < 0.001). Multivariate regression suggested that NKD2 was independently prognostic factors in terms of progression-free survival (hazard ratio: 2.91; 95% confidence interval: 1.61–5.27, P < 0.001) and overall survival (hazard ratio: 3.6; 95% confidence interval: 1.80–7.21, P < 0.001). In vitro studies further demonstrated that NKD2 suppressed ovarian cancer cell proliferation, colony formation and cell migration.Conclusion: NKD2 is a novel prognostic marker and could suppress tumor progression in ovarian cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81702754)
This publication has 23 references indexed in Scilit:
- Myristoylated Naked2 Antagonizes Wnt-β-Catenin Activity by Degrading Dishevelled-1 at the Plasma MembraneJournal of Biological Chemistry, 2010
- Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomasInternational Journal of Cancer, 2010
- Convergence between Wnt-β-catenin and EGFR signaling in cancerMolecular Cancer, 2010
- Mutations in the Human naked cuticle Homolog NKD1 Found in Colorectal Cancer Alter Wnt/Dvl/β-Catenin SignalingPLOS ONE, 2009
- Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literatureJournal of Ovarian Research, 2009
- Naked2 Acts as a Cargo Recognition and Targeting Protein to Ensure Proper Delivery and Fusion of TGF-α–containing Exocytic Vesicles at the Lower Lateral Membrane of Polarized MDCK CellsMolecular Biology of the Cell, 2007
- PR130 is a modulator of the Wnt-signaling cascade that counters repression of the antagonist Naked cuticleProceedings of the National Academy of Sciences, 2006
- Transient activation of β-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumoursDevelopment, 2004
- Myristoylated Naked2 escorts transforming growth factor α to the basolateral plasma membrane of polarized epithelial cellsProceedings of the National Academy of Sciences, 2004
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002